Unknown

Dataset Information

0

Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.


ABSTRACT: COVID-19 may cause pneumonia, acute respiratory distress syndrome, cardiovascular alterations, and multiple organ failure, which have been ascribed to a cytokine storm, a systemic inflammatory response, and an attack by the immune system. Moreover, an oxidative stress imbalance has been demonstrated to occur in COVID-19 patients. N- Acetyl-L-cysteine (NAC) is a precursor of reduced glutathione (GSH). Due to its tolerability, this pleiotropic drug has been proposed not only as a mucolytic agent, but also as a preventive/therapeutic agent in a variety of disorders involving GSH depletion and oxidative stress. At very high doses, NAC is also used as an antidote against paracetamol intoxication. Thiols block the angiotensin-converting enzyme 2 thereby hampering penetration of SARS-CoV-2 into cells. Based on a broad range of antioxidant and anti-inflammatory mechanisms, which are herein reviewed, the oral administration of NAC is likely to attenuate the risk of developing COVID-19, as it was previously demonstrated for influenza and influenza-like illnesses. Moreover, high-dose intravenous NAC may be expected to play an adjuvant role in the treatment of severe COVID-19 cases and in the control of its lethal complications, also including pulmonary and cardiovascular adverse events.

SUBMITTER: De Flora S 

PROVIDER: S-EPMC7436914 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.

De Flora Silvio S   Balansky Roumen R   La Maestra Sebastiano S  

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20200811 10


COVID-19 may cause pneumonia, acute respiratory distress syndrome, cardiovascular alterations, and multiple organ failure, which have been ascribed to a cytokine storm, a systemic inflammatory response, and an attack by the immune system. Moreover, an oxidative stress imbalance has been demonstrated to occur in COVID-19 patients. N- Acetyl-L-cysteine (NAC) is a precursor of reduced glutathione (GSH). Due to its tolerability, this pleiotropic drug has been proposed not only as a mucolytic agent,  ...[more]

Similar Datasets

| S-EPMC8086623 | biostudies-literature
| S-EPMC7995409 | biostudies-literature
| S-EPMC8274825 | biostudies-literature
| S-EPMC7542597 | biostudies-literature
2023-03-24 | GSE222393 | GEO
| S-EPMC9651994 | biostudies-literature
| S-EPMC7850220 | biostudies-literature
| S-EPMC7584839 | biostudies-literature
| S-EPMC9253300 | biostudies-literature
| S-EPMC7568461 | biostudies-literature